Stock Track | Cogent Biosciences Soars 5.42% Intraday on Positive Analyst Ratings

Stock Track

02/18

Cogent Biosciences, Inc. (COGT) saw its stock price surge 5.42% during intraday trading on Wednesday, marking a significant upward movement.

The sharp rise appears to be driven by positive analyst sentiment. Wedbush analyst David Nierengarten maintained a Buy rating on the company with a price target of $55.00 in a report released today. This bullish outlook from a prominent analyst likely fueled investor confidence and buying activity in the stock.

Other analysts have also been actively providing ratings on Cogent Biosciences as part of broader coverage of the healthcare sector, contributing to the heightened market attention on the company.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1129943619"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1129943619\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1129943619?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-18 22:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1129943619","market":"us","top_or_hot":-1,"title":"Stock Track | Cogent Biosciences Soars 5.42% Intraday on Positive Analyst Ratings","media":"Stock Track","content":"<p>Cogent Biosciences, Inc. (COGT) saw its stock price surge 5.42% during intraday trading on Wednesday, marking a significant upward movement.</p><p>The sharp rise appears to be driven by positive analyst sentiment. Wedbush analyst David Nierengarten maintained a Buy rating on the company with a price target of $55.00 in a report released today. This bullish outlook from a prominent analyst likely fueled investor confidence and buying activity in the stock.</p><p>Other analysts have also been actively providing ratings on Cogent Biosciences as part of broader coverage of the healthcare sector, contributing to the heightened market attention on the company.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Cogent Biosciences Soars 5.42% Intraday on Positive Analyst Ratings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Cogent Biosciences Soars 5.42% Intraday on Positive Analyst Ratings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-18 22:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Cogent Biosciences, Inc. (COGT) saw its stock price surge 5.42% during intraday trading on Wednesday, marking a significant upward movement.</p><p>The sharp rise appears to be driven by positive analyst sentiment. Wedbush analyst David Nierengarten maintained a Buy rating on the company with a price target of $55.00 in a report released today. This bullish outlook from a prominent analyst likely fueled investor confidence and buying activity in the stock.</p><p>Other analysts have also been actively providing ratings on Cogent Biosciences as part of broader coverage of the healthcare sector, contributing to the heightened market attention on the company.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"COGT","symbol_name":"Cogent Biosciences, Inc.","start_time":0,"source_url":"","article_id":"1129943619","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1129943619","pubTimestamp":1771425804,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Cogent Biosciences, Inc. (COGT) saw its stock price surge 5.42% during intraday trading on Wednesday, marking a significant upward movement.The sharp rise appears to be driven by positive analyst...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"COGT":"Cogent Biosciences, Inc."},"translate_title":"个股追踪|分析师正面评级Cogent Biosciences盘中大涨5.42%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"COGT":1},"content_text":"Cogent Biosciences, Inc. (COGT) saw its stock price surge 5.42% during intraday trading on Wednesday, marking a significant upward movement.The sharp rise appears to be driven by positive analyst sentiment. Wedbush analyst David Nierengarten maintained a Buy rating on the company with a price target of $55.00 in a report released today. This bullish outlook from a prominent analyst likely fueled investor confidence and buying activity in the stock.Other analysts have also been actively providing ratings on Cogent Biosciences as part of broader coverage of the healthcare sector, contributing to the heightened market attention on the company.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}